160 related articles for article (PubMed ID: 35967322)
21. C-C motif chemokine receptor 9 positive macrophages activate hepatic stellate cells and promote liver fibrosis in mice.
Chu PS; Nakamoto N; Ebinuma H; Usui S; Saeki K; Matsumoto A; Mikami Y; Sugiyama K; Tomita K; Kanai T; Saito H; Hibi T
Hepatology; 2013 Jul; 58(1):337-50. PubMed ID: 23460364
[TBL] [Abstract][Full Text] [Related]
22. CCR9+ T cells contribute to the resolution of the inflammatory response in a mouse model of intestinal amoebiasis.
Rojas-López AE; Soldevila G; Meza-Pérez S; Dupont G; Ostoa-Saloma P; Wurbel MA; Ventura-Juárez J; Flores-Romo L; García-Zepeda EA
Immunobiology; 2012 Aug; 217(8):795-807. PubMed ID: 22633147
[TBL] [Abstract][Full Text] [Related]
23. CCR9+ macrophages are required for acute liver inflammation in mouse models of hepatitis.
Nakamoto N; Ebinuma H; Kanai T; Chu PS; Ono Y; Mikami Y; Ojiro K; Lipp M; Love PE; Saito H; Hibi T
Gastroenterology; 2012 Feb; 142(2):366-76. PubMed ID: 22079594
[TBL] [Abstract][Full Text] [Related]
24. Expression of CCR9 in HTLV-1+ T cells and ATL cells expressing Tax.
Nagakubo D; Jin Z; Hieshima K; Nakayama T; Shirakawa AK; Tanaka Y; Hasegawa H; Hayashi T; Tsukasaki K; Yamada Y; Yoshie O
Int J Cancer; 2007 Apr; 120(7):1591-7. PubMed ID: 17205512
[TBL] [Abstract][Full Text] [Related]
25. Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes.
Papadakis KA; Zhu D; Prehn JL; Landers C; Avanesyan A; Lafkas G; Targan SR
J Immunol; 2005 Apr; 174(8):4985-90. PubMed ID: 15814728
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance and prospective molecular mechanism of C‑C motif chemokine receptors in patients with early‑stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.
Zhou X; Liao X; Wang X; Huang K; Yang C; Yu T; Liu J; Han C; Zhu G; Su H; Qin W; Han Q; Liu Z; Huang J; Gong Y; Ye X; Peng T
Oncol Rep; 2019 Nov; 42(5):1856-1868. PubMed ID: 31432181
[TBL] [Abstract][Full Text] [Related]
27. C
Saito M; Suzuki H; Harigae Y; Li G; Tanaka T; Asano T; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Apr; 41(2):120-124. PubMed ID: 35471047
[TBL] [Abstract][Full Text] [Related]
28. Involvement of CCR9 at multiple stages of adult T lymphopoiesis.
Svensson M; Marsal J; Uronen-Hansson H; Cheng M; Jenkinson W; Cilio C; Jacobsen SE; Sitnicka E; Anderson G; Agace WW
J Leukoc Biol; 2008 Jan; 83(1):156-64. PubMed ID: 17911179
[TBL] [Abstract][Full Text] [Related]
29. Selectively increased expression and functions of chemokine receptor CCR9 on CD4+ T cells from patients with T-cell lineage acute lymphocytic leukemia.
Qiuping Z; Qun L; Chunsong H; Xiaolian Z; Baojun H; Mingzhen Y; Chengming L; Jinshen H; Qingping G; Kejian Z; Zhimin S; Xuejun Z; Junyan L; Jinquan T
Cancer Res; 2003 Oct; 63(19):6469-77. PubMed ID: 14559839
[TBL] [Abstract][Full Text] [Related]
30. Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor gammadelta(+) gut intraepithelial lymphocytes.
Wurbel MA; Malissen M; Guy-Grand D; Meffre E; Nussenzweig MC; Richelme M; Carrier A; Malissen B
Blood; 2001 Nov; 98(9):2626-32. PubMed ID: 11675330
[TBL] [Abstract][Full Text] [Related]
31. Repression of Ccr9 transcription in mouse T lymphocyte progenitors by the Notch signaling pathway.
Krishnamoorthy V; Carr T; de Pooter RF; Emanuelle AO; Gounari F; Kee BL
J Immunol; 2015 Apr; 194(7):3191-200. PubMed ID: 25710912
[TBL] [Abstract][Full Text] [Related]
32. MLN3126, an antagonist of the chemokine receptor CCR9, ameliorates inflammation in a T cell mediated mouse colitis model.
Igaki K; Komoike Y; Nakamura Y; Watanabe T; Yamasaki M; Fleming P; Yang L; Soler D; Fedyk E; Tsuchimori N
Int Immunopharmacol; 2018 Jul; 60():160-169. PubMed ID: 29730559
[TBL] [Abstract][Full Text] [Related]
33. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.
Johnson EL; Singh R; Singh S; Johnson-Holiday CM; Grizzle WE; Partridge EE; Lillard JW
World J Surg Oncol; 2010 Jul; 8():62. PubMed ID: 20649989
[TBL] [Abstract][Full Text] [Related]
34. Development of a Sensitive Anti-Human CCR9 Monoclonal Antibody (C
Tanaka T; Suzuki H; Isoda Y; Asano T; Nakamura T; Yanaka M; Handa S; Takahashi N; Okuno S; Yoshikawa T; Li G; Nanamiya R; Goto N; Tateyama N; Okada Y; Kobayashi H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Dec; 41(6):303-310. PubMed ID: 36383113
[TBL] [Abstract][Full Text] [Related]
35. CCR9-mediated signaling through β-catenin and identification of a novel CCR9 antagonist.
Lee S; Heinrich EL; Li L; Lu J; Choi AH; Levy RA; Wagner JE; Yip ML; Vaidehi N; Kim J
Mol Oncol; 2015 Oct; 9(8):1599-611. PubMed ID: 26003048
[TBL] [Abstract][Full Text] [Related]
36. CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion.
Johnson-Holiday C; Singh R; Johnson EL; Grizzle WE; Lillard JW; Singh S
World J Surg Oncol; 2011 May; 9():46. PubMed ID: 21539750
[TBL] [Abstract][Full Text] [Related]
37. Monocytes/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiation.
Schmutz C; Cartwright A; Williams H; Haworth O; Williams JH; Filer A; Salmon M; Buckley CD; Middleton J
Arthritis Res Ther; 2010; 12(4):R161. PubMed ID: 20738854
[TBL] [Abstract][Full Text] [Related]
38. Molecular cloning and expression analysis of the canine chemokine receptor CCR9.
Maeda S; Ohno K; Tsukamoto A; Nakashima K; Fukushima K; Goto-Koshino Y; Fujino Y; Tsujimoto H
Vet Immunol Immunopathol; 2012 Jan; 145(1-2):534-9. PubMed ID: 22209203
[TBL] [Abstract][Full Text] [Related]
39. Wnt5a and CCL25 promote adult T-cell acute lymphoblastic leukemia cell migration, invasion and metastasis.
Deng X; Tu Z; Xiong M; Tembo K; Zhou L; Liu P; Pan S; Xiong J; Yang X; Leng J; Zhang Q; Xiao R; Zhang Q
Oncotarget; 2017 Jun; 8(24):39033-39047. PubMed ID: 28380463
[TBL] [Abstract][Full Text] [Related]
40. CCR9 Expressing T Helper and T Follicular Helper Cells Exhibit Site-Specific Identities During Inflammatory Disease.
Cosorich I; McGuire HM; Warren J; Danta M; King C
Front Immunol; 2018; 9():2899. PubMed ID: 30662436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
